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MaAccurate assessment of the left main coronary artery (LMCA) is critical in determining treatment strategies and delin-
eating revascularization options to improve prognosis. There has been an evolution in invasive techniques that allow
detailed assessment of both function and anatomy. As technologies advance, there is an increasing amount of evidence
supporting the use of percutaneous coronary intervention for the LMCA. This state-of-the-art paper provides an in-depth
exploration of intravascular ultrasound, fractional ﬂow reserve, and optical coherence tomography. A discussion is
provided that explores the basis for application of these technologies, the body of evidence for each modality and its use
in LMCA assessment, and the potential role in post-PCI optimization in what is a dynamically changing ﬁeld.
(J Am Coll Cardiol Intv 2015;8:1529–39) © 2015 by the American College of Cardiology Foundation.S igniﬁcant left main coronary artery (LMCA)atherosclerotic disease is increasingly viewedas being treatable by percutaneous coronary
intervention (PCI) in selected groups. With evolving
technologies and techniques, a number of random-
ized control trials have suggested that speciﬁc groups
of patients may achieve favorable outcomes with
PCI compared with coronary artery bypass grafting
(CABG). There is also an increasing awareness of the
need for accurate assessment and evaluation of the
true signiﬁcance of LMCA lesions, particularly if
angiographically moderate or equivocal. Angiography
and conventional grayscale intravascular ultrasound
(IVUS), the mainstays of LMCA assessment for some
time, are increasingly being supported by the com-
plementary use of other advanced intravascular
modalities of assessment, namely fractional ﬂow
reserve (FFR) and optical coherence tomography
(OCT). These varied and improved techniques also
allow for further optimization of PCI of the LMCA,
with the potential for improvements in patient
outcomes.m the Cardiology Department, Concord Repatriation General Hospital, a
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nuscript received May 29, 2015; revised manuscript received July 14, 201This review therefore examines the current status
of percutaneous assessment of the LMCA using the
currently available technologies, with an emphasis on
their relative strengths and limitations, and likely
future directions in what is a rapidly changing ﬁeld of
interventional cardiology.
LMCA DISEASE: AN OVERVIEW
It has been recognized for over one-half century that
signiﬁcant LMCA disease is associated with a poor
prognosis, with 3-year mortality rates in the pre-
revascularization era as high as 63% in high-risk
subgroups (1). This is due to the large amount of
myocardium at risk if there is signiﬁcant ﬂow limita-
tion, as the LMCA supplies up to 84% of the blood ﬂow
to the left ventricle in a right-dominant coronary
system (2). The mortality beneﬁt with surgical revas-
cularization has been well established, and thus it has
long been the standard of care.
The LMCA itself may be divided into the ostium,
trunk, and distal vessel. IVUS studies assessing plaquend the University of Sydney, Sydney, Australia. Drs.
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ABBR EV I A T I ON S
AND ACRONYMS
CABG = coronary artery bypass
grafting
FFR = fractional ﬂow reserve
IVUS = intravascular
ultrasound
LAD = left anterior
descending artery
LCx = left circumﬂex artery
LMCA = left main coronary
artery
MLA = minimal luminal area
OCT = optical coherence
tomography
PCI = percutaneous coronary
intervention
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1530composition in the LMCA suggest athero-
sclerotic plaque of the LMCA is qualitatively
different from elsewhere in the coronary tree,
with minimal necrotic core content (3) and
less thin cap ﬁbroatheroma (TCFA) than the
proximal segments of the other coronary
arteries (3,4), particularly the left anterior
descending artery (LAD), which is more prone
to plaque ruptures (5,6). In addition, the dis-
tribution of atherosclerosis may also be
different in the LMCA, with distal disease that
encroaches on the bifurcation into the LAD
and left circumﬂex artery (LCx) more com-
mon than proximal or midvessel disease (7).
This increased frequency of distal LMCA dis-
ease is associated with greater technical dif-
ﬁculty when undergoing PCI and attendantprognostic implications compared with treatment of
ostial or midshaft lesions (8,9). The prevalence of
LMCA disease in patients referred for invasive angi-
ography is approximately 4%, with 5% to 10% of these
patients having isolated LMCA disease (10,11). In
addition to native disease, iatrogenic LMCA disease is
rare but well documented and may include dissection
or stenosis following catheterization or ostial stenosis
after aortic valve surgery (12,13).
PCI VERSUS CABG FOR LMCA DISEASE
CABG has been the mainstay of LMCA disease,
although PCI in this setting was ﬁrst proposed in 1980
(14). Current evidence supporting PCI for LMCA dis-
ease is on the basis of 4 randomized controlled trials
(RCTs) that were summarized recently (15), which
have resulted in a rising prevalence of LMCA percu-
taneous revascularization. When LMCA PCI is un-
dertaken, there is therefore an increasing need to
achieve optimal procedural outcomes using all avail-
able technologies.
INVASIVE ASSESSMENT
Accurate assessment of LMCA disease is important to
guide appropriate risk stratiﬁcation and treatment
allocation. Conventionally, an angiographic cut-off
of $50% diameter stenosis (equivalent to $75% area
stenosis) has been used to indicate hemodynamic
signiﬁcance, which is on the basis of early work in an
animal model by Gould that demonstrated a reduc-
tion in hyperemic ﬂow across lesions beyond this
degree of stenosis. Angiographic assessment of the
LMCA is made problematic, however, by inherent
difﬁculties speciﬁc to or of increased importance at
this site. These include a short vessel segment, lack ofa reference vessel, eccentricity, remodeling, potential
for missed ostial disease due to deep catheter place-
ment, overlapping daughter branches, and frequent
foreshortening on angiography (16,17). Although
various techniques such as quantitative coronary
angiography (QCA) and 3-dimensional (3D) QCA
provide valuable advances in non-LMCA coronary
disease (18), they remain subject to many of these
inherent anatomical limitations. As a consequence,
adjunctive invasive modalities are particularly perti-
nent for the assessment of LMCA disease (Figure 1).
INTRAVASCULAR ULTRASOUND
BACKGROUND. First introduced in 1988, grayscale
IVUS has been the mainstay for LMCA assessment in
equivocal lesions for over 2 decades and is compre-
hensively reviewed elsewhere (19).
A number of methods of post-processing have
been applied to improve grayscale IVUS image quality
and provide so called “tissue characterization.” These
include virtual histology IVUS and integrated back-
scatter IVUS, also reviewed in detail elsewhere
(20,21). These methods rely on raw radiofrequency
analysis of the original image and have been pro-
posed to give further information on tissue charac-
terization, with distinct signals for ﬁbrous, ﬁbrofatty,
necrotic, and calciﬁc material (21) that have attendant
prognostic implications (22). These techniques have
been validated in vitro and in vivo (23), although
there remains debate as to their reliability.
LMCA ASSESSMENT. A number of trials have assessed
the use of IVUS in evaluating LMCA disease. Early
studies proposed a minimal luminal area (MLA) #9.0
mm2 or an area stenosis $50% to determine a hemo-
dynamically signiﬁcant LMCA stenosis (24). This
threshold was then reduced by Fassa et al. (25), who
determined a lower limit of normal LMCA MLA as 7.5
mm2 after studying a cohort with angiographically
normal LMCA. At 3.3 years, there was no difference in
major adverse cardiovascular events between medi-
cally managed patients and those who were revascu-
larized using this threshold (25). As well as providing
more reliable data than angiography regarding lumen
size, IVUS is more readily able to examine ostial dis-
ease and, through direct lumen visualization, can
overcome difﬁculties with lesion eccentricity and
oblique catheter position that can result in contrast
streaming (26). Such precise imaging using IVUS pre-
PCI may reduce stent protrusion into the aorta.
Of particular interest is the distribution and nature
of plaque within the LMCA, which, as mentioned
previously, has less necrotic core and TCFA than the
proximal LAD, whereas the preponderance of LMCA
FIGURE 1 LMCA Imaged With Angiography, OCT, and IVUS 1 Year Following Implantation of a DES
(A) Angiography (RAO view) demonstrating mild proximal LMCA lesion and adequate stent expansion in the midvessel. (B) OCT, midvessel. Stent
struts are imaged in great detail, appearing well apposed to the vessel wall (arrows). *Wire artefact shadow. (C) IVUS, midvessel. Adequate stent
strut apposition is shown, but precision is lacking compared with OCT (arrows). (D) OCT, ostium. The lumen is clearly seen with an MLA 7.1 mm2,
but no detail is provided regarding the nature or extent of underlying atherosclerotic plaque. (E) IVUS, ostium. The lumen is well visualized
with an MLA 6 mm2; additionally, the burden of atherosclerotic plaque is evident (arrow; calculated 40% area stenosis). DES ¼ drug-eluting
stent; IVUS ¼ intravascular ultrasound; LMCA ¼ left main coronary artery; MLA ¼ minimal luminal area; OCT ¼ optical coherence tomography;
RAO ¼ right anterior oblique. Reprinted with permission from Moharram et al. (64).
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1531disease involves the distal bifurcation (27). Oviedo
et al. (27) demonstrated that plaque extending
into the proximal LAD, LCx, or both may be seen
in 90%, 66.4%, and 62% of patients, respectively,
whereas ostial daughter vessel lesions without LMCAinvolvement were present in only 9.3% of LAD and
17.1% of LCx vessels. The carina was always spared.
This frequent involvement of the distal bifurcation
is of importance when assessing suitability for PCI,
as it is an independent predictor of adverse
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1532outcomes compared with ostial or midshaft lesions
(8,9). The MLA at the bifurcation has been suggested
as a marker of disease severity and capacity for stent
expansion (28).
Corre lat ion with FFR. Following the development
of FFR, several studies investigated the relationship
between IVUS and FFR. A lower IVUS MLA threshold
was proposed by Jasti et al. (29) using an FFR <0.75 as
the gold standard. In this study of 55 patients with
angiographically intermediate lesions, an MLA of
5.9 mm2 and a minimum lumen diameter of 2.8 mm
achieved the highest sensitivity and speciﬁcity
compared with FFR (29). This same MLA threshold
was validated in the Spanish Working Group on
Interventional Cardiology (LITRO) study, with 2-year
cardiac death–free survival of 97.7% in the deferred
group and 94.5% in the revascularized group (p ¼ 0.5)
(30). More recently, Kang et al. (31) have reported an
MLA <4.8 mm2 as best correlating with an FFR <0.80
(89% sensitivity and 83% speciﬁcity), and Park et al.
(32) derived an MLA cut-off of #4.5mm2 to predict an
FFR #0.80 with 77% sensitivity and 82% speciﬁcity.
Of relevance is that these latter 2 studies proposing
smaller MLAs were carried out in Asian populations.
Patient body mass index or body surface area was not
accounted for by Kang et al. (31), and the mean body
mass index ( SD) in the study by Park et al. (32) was
24.5  3.2 kg/m2. Although this value was adjusted
for, the accuracy of these cut-offs has not been
determined in other ethnic groups.
These data would suggest that a deferral strategy
may be safe in the short- to medium-term if the IVUS-
derived LMCA MLA is >6 mm2 or minimum lumen
diameter >2.8 mm; this is a commonly proposed
practice (19). Identifying a cut-off with adequate
accuracy when compared to FFR, however, remains
challenging.
POST-PCI. As a consequence of the ability of IVUS to
accurately assess lumen size, lesion length and
composition, and stent strut apposition, its use to
assist PCI has been explored in the last 2 decades.
Early IVUS studies throughout the coronary tree
demonstrated a signiﬁcant rate of stent under-
expansion despite an adequate angiographic result,
with 1 study reporting 80% of lesions requiring post-
dilation on the basis of IVUS (33). In landmark
studies, Colombo et al. (34) subsequently reported
the safe implantation of stents without post-PCI
anticoagulation following stent optimization with
IVUS. Subsequent data supported the role of plaque
burden and stent underexpansion as assessed by
IVUS in stent thrombosis and restenosis and the po-
tential reduction in stent thrombosis and repeat
revascularization with IVUS-guided PCI (35,36).The goal of LMCA stent optimization with IVUS
has, therefore, been examined in recent years. There
are, however, no RCT data available. The principal
data comes from 2 registry cohorts: the Korean
MAIN-COMPARE (Revascularization for Unprotected
Left Main Coronary Stenosis: Comparison of PTCA
Versus Surgical Revascularization) registry and a
pooled Spanish registry (37,38). From the MAIN-
COMPARE registry, an analysis of 145 matched pairs
receiving ﬁrst-generation drug-eluting stents (DES)
showed a mortality beneﬁt with IVUS-guided LMCA
stenting versus angiography alone at 3 years (4.7% vs.
16%; p ¼ 0.048) (37). A similar beneﬁt was not seen
with bare-metal stents. This improvement in outcomes
with IVUS-guided PCI was also seen in the larger
Spanish cohort comprising 505 matched pairs under-
going DES implantation. At 3 years, there was a sig-
niﬁcant reduction in death (7.4% vs. 13%; p ¼ 0.01),
death/myocardial infarction (MI)/target lesion revas-
cularization (14.4% vs. 22.2%; p¼ 0.006), and deﬁnite/
probable stent thrombosis (0.6% vs. 2.2%) with IVUS-
guided PCI (38). Importantly, unstable patients with
LMCA disease often undergo PCI without IVUS guid-
ance, leading to a potential selection bias that may
have inﬂuenced outcomes in these registries. Unmea-
sured confounders make this population difﬁcult to
adjust for in registries.
In the absence of randomized data, these obser-
vational studies offer some support for the routine
use of IVUS to optimize LMCA PCI. Any criteria by
which IVUS is used for LMCA stent optimization are
nevertheless difﬁcult to prescribe. In both previously
mentioned studies, IVUS was used to guide stent strut
expansion according to individual operator prefer-
ence, without trial- or registry-based criteria (37–39);
this has been an approach widely adopted in clinical
practice.
FRACTIONAL FLOW RESERVE
BACKGROUND. In the last decade, the use of FFR
has become widespread practice as an invasive
means to assess the functional signiﬁcance of a
lesion (40). Following the landmark DEFER (Frac-
tional Flow Reserve to Determine the Appropriate-
ness of Angioplasty in Moderate Coronary Stenosis:
A Randomized Trial), and FAME (Fractional Flow
Reserve Versus Angiography for Multivessel Eval-
ucation Trial), and FAME 2 trials reviewed elsewhere
(41–43), FFR assessment of lesions in patients with
stable angina has become standard practice in the
cardiac catheterization laboratory, such that FFR
assessment of the LMCA has been approached with
enthusiasm.
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1533LMCA ASSESSMENT. Although the principles deter-
mining FFR apply equally to the LMCA as to other
points in the coronary tree, interestingly, the pres-
ence of LMCA disease was an exclusion criteria in theContinued in the next column
FIGURE 2 Angiography, FFR, and IVUS to Interrogate an
Intermediate LMCA LesionDEFER, FAME, and FAME 2 trials (43). Data to support
clinical use of FFR in LMCA assessment, however,
does come directly from a number of other smaller
trials (44–46). An important observation from these
trials is the demonstration of the safety of deferring
revascularization in patients without functionally
signiﬁcant LMCA disease as assessed by FFR. A recent
meta-analysis, which also incorporated a sample size
of 8 relevant trials (47), conﬁrmed no signiﬁcant
difference in the primary endpoint (all-cause death,
nonfatal MI, or revascularization), all-cause death, or
nonfatal MI. The rate of subsequent revasculariza-
tion, however, was signiﬁcantly higher in the medical
arm; whether this was primarily due to LMCA inter-
vention was not clear.
Of interest, Hamilos et al. (46) demonstrated a poor
correlation between angiography and FFR for assess-
ment of angiographically equivocal LMCA; interob-
server correlation between FFR and angiographic
signiﬁcance was only 52%. This probably reﬂects a
combination of the known modest correlations of FFR
and angiography seen generally and those anatomical
features speciﬁc to the LMCA discussed previously
(16,48).
An important limitation of LMCA FFR is the con-
founding effect of downstream stenoses, which are
present in the majority of patients with LMCA dis-
ease. Serial stenoses will each blunt hyperemic ﬂow,
thereby causing overestimation of the FFR for each
lesion (49). The LMCA, however, is different than a
serial stenosis in a single vessel in that there may be a
large side branch—an undiseased LAD or LCx—before
the second stenosis. Consequently, FFR of the LMCA
with the pressure wire in the nondiseased daughter
vessel remains reliable in the presence of a mild to
moderate lesion in the other daughter vessel (50).FIGURE 2 Continued
(A) Intermediate ostial/proximal LMCA lesion, moderate LAD
(white arrows), and minor LCx disease (LAO view). FFR with the
pressure sensor in the distal LAD is 0.71, suggesting signiﬁcant
ﬂow limitation from the combined effect of the LMCA and LAD
lesions. On pullback, FFR in the distal LMCA was 0.86. The LMCA
FFR may be falsely elevated in the presence of downstream
disease, although if the apparent FFR in LMCA is >0.85, it is
likely that the actual FFR remains >0.80. (B) FFR with the
pressure sensor in the distal LCx was 0.88, suggesting that the
cumulative effect of the LMCA and LCx disease was not signiﬁ-
cant. LAO caudal view. (C) IVUS of the LMCA yielded an MLA of
7.2 mm2, consistent with measured FFR and with mild disease
severity. FFR ¼ fractional ﬂow reserve; LAD ¼ left anterior
descending artery; LAO ¼ left anterior oblique; LCx ¼ left
circumﬂex artery; other abbreviations as in Figure 1.
FIGURE 3 Guide Catheter Selection for LMCA PCI
and Imaging
(A) Passive long-tipped guide catheters, such as EBU or XB,
allow deep engagement of the LMCA, providing strong support
for PCI but making ostial interrogation difﬁcult. (B) The short-
tipped JL4 guide catheter is ideal for achieving a position in the
aortic root near the ostium, allowing catheter disengagement for
interrogation of the entire LMCA including the ostium with IVUS.
This position, however, does not allow an optimal ﬂush to ach-
ieve a blood-free ﬁeld required by OCT. (C) The standard JL4
guide catheter can be positioned precisely at the ostium; a
complete ﬂush can be achieved while allowing imaging of the
ostium. CX ¼ circumﬂex; EBU ¼ extra Back-up; JL4 ¼ Judkins
Left 4; LAD ¼ left anterior descending; PCI ¼ percutaneous
coronary intervention; ST ¼ short tip; XB ¼ extra Back-up;
other abbreviations as in Figures 1 and 2.
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1534An animal model testing this conﬁguration in an
empiric manner demonstrated that an apparent
LMCA FFR of >0.80 in the setting of a true FFR <0.75
only occurs in the setting of severe and proximal
downstream disease (combined FFR #0.50) (51).
A subsequent human validation study demonstrated
a numerically small but signiﬁcant difference in
LMCA FFR with a downstream lesion; when the
apparent FFR exceeded 0.85, however, the true FFR
was always above 0.80, suggesting that this may
perhaps be of less clinical importance (52) (Figure 2).
The scenario of an intermediate LMCA lesion in the
presence of lesions in both the LAD and LCx remains
potentially problematic. Furthermore, given the
frequent involvement of the distal bifurcation and
presence of downstream disease, a pullback gradient
is often warranted to determine the location of
greatest functional ﬂow limitation and the relative
contribution of each lesion to the total ischemic
burden. FFR in this setting must be performed
meticulously and analyzed with caution. When in
doubt, an alternative imaging modality such as IVUS
or OCT may be desirable.
From a technical standpoint, FFR is generally less
challenging and quicker to perform than IVUS or OCT,
although the current generation of pressure-sensor
wires require careful handling in the coronary ar-
tery. The choice of intracoronary or intravenous
adenosine to induce hyperemia is operator depen-
dent, although in the case of LMCA disease, intrave-
nous adenosine allows for careful pullbacks and a
longer steady state that is often favorable. Impor-
tantly, adequate guide catheter disengagement
should be ensured to avoid the potential for a false
negative FFR due to guide catheter damping at an
ostial LMCA lesion.
FFR in LMCA lesion assessment is, therefore,
generally accepted as accurate and has entered com-
mon clinical practice, particularly in centers without
access to IVUS, although the caveats mentioned
require careful consideration.
POST-PCI. In non-LMCA coronary lesions, a number
of observational studies have demonstrated that FFR
post-PCI with bare-metal stents and DES correlates
with outcomes at 6 months and 1 year (53), and a
recent contemporary study of post-PCI IVUS and FFR
with second-generation DES conﬁrmed the ﬁnding of
increased major adverse cardiovascular events at a
mean of 17.8 months with lower residual FFR despite
optimal stent expansion (54). None of these studies
included LMCA disease. To the authors’ knowledge
there is no data supporting the use of FFR post-PCI for
stent optimization or prognostication. Additionally,
the ﬁnding of an abnormal FFR post-PCI may be due tolocal factors, such as inadequate stent deployment or
plaque disruption at the entry or exit of the stent, or
residual disease across the remaining arterial seg-
ments. It may be difﬁcult to identify those patients in
whom further stent optimization may improve ﬂow on
the basis of FFR alone. Conversely, stent under-
expansion or malapposition may not manifest imme-
diately post-PCI with ﬂow limitation. Consequently,
the need to ensure optimal stent expansion to reduce
the risk of stent thrombosis—particularly pertinent
in the setting of LMCA stenting, and not likely to be
reﬂected in FFR measurements—at present requires
interrogation using imaging rather than FFR post-PCI.
OPTICAL COHERENCE TOMOGRAPHY
BACKGROUND. OCT utilizes light in a similar fashion
to sound waves in IVUS imaging. A blood-free ﬁeld is
required for image acquisition, which is achieved by
injection of saline or contrast during an automated
pullback of the OCT catheter. In contrast to IVUS, OCT
FIGURE 4 Angiography and OCT of an LMCA Lesion Pre- and Post-PCI
(A) Initial right anterior oblique cranial view showing a distal LMCA lesion extending into the proximal LAD (segment between arrows).
(B) Adequate angiographic appearance after stenting (segment between arrows). The arrowhead indicates the point at which images C and D
were taken. (C) OCT demonstrates stent-strut malapposition (arrows; *maximal strut malapposition at 290 mm). (D) OCT after post-inﬂation
now shows adequate stent strut apposition. Abbreviations as in Figures 1 to 3. Reprinted with permission from Alcock et al. (67).
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1535offers greater spatial resolution (15 mm vs. 100 mm) at
the cost of tissue penetration (2.0 mm vs. 10 mm) (20).
OCT is able to accurately assess ﬁbrous cap thick-
ness and plaque composition, thereby allowing
identiﬁcation of TCFA (ﬁbrous cap <65 mm, lipid
occupying $2 quadrants of cross-sectional area) (55).
Compared with IVUS, OCT is able to more precisely
delineate the lumen and vessel wall in phantom
models (56). Importantly, OCT results in measured
luminal areas of 9% less than IVUS in such models,
with areas measured by QCA 5% further smaller than
OCT (56,57). Plaque-associated lipid, plaque rupture,
ﬁbrous cap erosion, plaque-associated thrombus, and
TCFA are also more frequently detected compared to
IVUS (58).
LMCA ASSESSMENT. When compared with FFR,
however, as might be expected, OCT performs in asimilarly modest fashion to IVUS, with a low spec-
iﬁcity at a suggested optimal MLA of 1.95 mm2 to
detect an ischemic lesion in a non-LMCA vessel
(59). The main technological disadvantages with
OCT are the ability to differentiate lipid from cal-
cium deposits and a shallow depth of penetration,
which limits assessment of plaque burden (55),
often an important consideration in LMCA treat-
ment. A recent analysis of 15 studies conﬁrmed the
correlation between IVUS MLA and FFR in LMCA
disease but no data to support the role of OCT in
this setting (60).
In addition, a technical limitation of OCT, which
applies in particular to the LMCA, is the need to ﬂush
the lumen to achieve a blood-free ﬁeld. This renders
adequate assessment of ostial LMCA lesions more
difﬁcult. Although IVUS may be performed with the
CENTRAL ILLUSTRATION OCT/FFR Evaluation of Moderate LMCA
Lesion
Bing, R. et al. J Am Coll Cardiol Intv. 2015; 8(12):1529–39.
Schematic for imaging and pressure wire evaluation of left main stem disease. Within the
cut-away section of the left main, the atherosclerotic lesion is evident. Imaged using
Optical Coherence Tomography (OCT), with eccentric irregular lesion demonstrated
(indicated by “OCT Image”). Distal pressure wire evaluation provides pullback fractional
ﬂow reserve (FFR) (indicated by “FFR tracing”). For detailed explanation see text
throughout. LMCA ¼ left main coronary artery.
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1536catheter disengaged from the artery, OCT in this
setting requires the selection and positioning of a
guide catheter precisely at the ostium to allow an
adequate ﬂush of the lumen during pullback. This
was initially viewed as a contraindication to OCT in
LMCA assessment (15) but is now more commonly
regarded as a manageable limitation (61) (Figure 3).
POST-PCI. The intuitive appeal of OCT to aid opti-
mization of PCI, which has speciﬁc relevance to the
LMCA, is clear. The high spatial resolution allowsexcellent stent strut visualization and better imaging
of subsequent stent coverage and neointimal hyper-
plasia than IVUS (62–64). Uncovered stent struts
visualized by OCT have been shown to be associated
with late stent thrombosis (65). A number of series
have therefore utilized OCT to study stent strut
exposure and endothelialization (55). OCT also offers
better identiﬁcation of adverse features such as
stent underexpansion, stent malapposition, or edge
dissection. An unmatched retrospective observa-
tional study comparing angiography-guided PCI and
frequency-domain OCT-guided PCI (335 patients in
each arm) showed detection of adverse features
requiring further stenting or balloon dilation in 34.7%
of the OCT arm. After multivariate analysis adjusting
for baseline and procedural differences, OCT guid-
ance appeared to reduce the risk of death or MI at
1 year (odds ratio: 0.49; p ¼ 0.037) and was without
complications (66). The superior ability of OCT to
detect complications when compared with angiog-
raphy is not unexpected, this single study notwith-
standing; however, routine or even frequent use of
OCT to guide PCI generally has not become wide-
spread practice.
There is no comparable data for OCT-guided PCI in
the LMCA. OCT-guided LMCA stenting has been pro-
posed (67) (Figure 4), and in a single-center study,
Fujino et al. (61) prospectively enrolled 33 patients
undergoing PCI with DES of the LMCA and performed
OCT post-PCI and at 9 months. Signiﬁcant rates of
stent malapposition (5.3% in the ostium/body) were
noted despite high-pressure inﬂations, with an asso-
ciated decrease in neointimal proliferation at follow-
up, although no events occurred in this small
cohort. Thus, there are currently no data regarding
OCT-derived lumen sizes pre- or post-LMCA inter-
vention, although its use holds appeal.
Similarly, to date, there are no large randomized
trials demonstrating improvements in outcome with
OCT-guided PCI generally nor in PCI isolated to the
LMCA. Although the additional information offered
by this high-resolution imaging modality is intui-
tively attractive, the clinical beneﬁt derived from this
is yet to be demonstrated. Ongoing registry data such
as the Massachusetts General Hospital OCT registry
may prove useful in this regard (68).
CURRENT GUIDELINES FOR
LMCA ASSESSMENT
An FFR #0.80 is incorporated in the 2012 American
College of Cardiology Foundation/American Heart
Association guidelines as a measure of a lesion’s
functional signiﬁcance, without specifying the lesion
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1537site (69). The 2014 European Society of Cardiology
guidelines (70) strongly recommend FFR to identify
relevant lesions in the absence of other ischemic
testing (Class I, Level of Evidence: A) and support
FFR-guided PCI in stable multivessel disease (Class
IIa, Level of Evidence: B). IVUS for assessment of
LMCA disease and optimization of PCI receives a
Class IIa recommendation (Level of Evidence: B).
OCT to assess for stent-related mechanical problems
in in-stent restenosis is given a Class IIa recommen-
dation (Level of Evidence: C), whereas use of OCT
for stent optimization in selected patients is given a
Class IIb recommendation (Level of Evidence: C)
(Central Illustration).
FUTURE DIRECTIONS
The results of the EXCEL (Everolinus-Eluting Stent
Versus Coronary Artery Bypass Surgery for Effec-
tiveness of Left Main Revascularization) trial are
highly anticipated as a contemporary RCT addressing
the use of second-generation DES versus current
surgical techniques for unprotected LMCA disease of
low to intermediate risk (SYNTAX score #32); a
beneﬁt shown by these data would likely drive
further interest in LMCA assessment for PCI.
Further advances in pressure wire technology are
also likely to contribute to the increased utilization of
FFR, with the recent deployment of a new nitinol-
based optical FFR guidewire. The instantaneous
wave-free ratio (iFR), a vasodilator-free index of lesion
severity measured by translesional pressure during
diastole, is appealing because it has no requirementfor hyperemia but has generated signiﬁcant debate.
The iFR is yet to be validated in an RCT (71), although
a preliminary study has demonstrated a correla-
tion between iFR and FFR in intermediate LMCA
disease (72).
Finally, 3D OCT has been proposed, with the
ability to accurately depict luminal geometry stent
strut integrity and side branch relationships (73).
Emerging studies have examined the role of bifur-
cation assessment during PCI (74). Although 3D QCA
and IVUS assessment of bifurcations pre- and post-
PCI have been investigated (75), the role of OCT
and the application of advanced imaging for the
LMCA bifurcation has yet to receive widespread
application.
CONCLUSIONS
Novel percutaneous transcatheter technologies have
the potential to signiﬁcantly inﬂuence detection of
LMCA disease, improve assessment of LMCA lesion
severity, aid with decisions regarding revasculariza-
tion, guide PCI, and optimize post-PCI results. Given
the prognostic signiﬁcance of LMCA disease, these
advances have the potential to substantially inﬂuence
patient outcomes in what is a rapidly changing ﬁeld
of coronary intervention.
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